A total of 160 834 5-year AYA cancer survivors (aged 15–39 years at diagnosis) were included, representing 2 239 390 person-years of follow-up. Overall, 2910 CVD deaths occurred, which was 1.4-fold [95% confidence interval (CI) 1.3–1.4] that expected in the general population, corresponding to 3.6 (95% CI 3.2–3.9) excess CVD deaths per 10 000 person-years. The highest risk of cardiac mortality was experienced after Hodgkin’s lymphoma (HL), and the highest risk of cerebrovascular mortality was observed with central nervous system (CNS) tumors. Even survivors in their 6th and 7th decades of life, the risk of CVD mortality remained markedly higher than that of the matched general population. Competing risk analysis showed that the cumulative mortality of CVD was elevated among AYA cancer survivors compared with childhood cancer survivors during the whole study period.
Long-term AYA cancer survivors have a greater risk of CVD mortality than the US general population and childhood cancer survivors. Vulnerable subgroups, especially survivors of HL and CNS tumors, require continued close follow-up care for cardiovascular conditions throughout survivorship.
more recommended stories
-
ChatGPT Excels in Medical Summaries, Lacks Field-Specific Relevance
In a recent study published in.
-
Study finds automated decision minimizes high-risk medicine combinations in ICU patients
A multicenter study coordinated by Amsterdam.
-
Study Discovers Connection Between Omicron Infection and Brain Structure Changes in Men
A recent study in the JAMA.
-
Advancing COPD Prognosis: Deep Learning Models
Researchers conducted a meta-analysis in a.
-
4 in 1 Test for Swine Flu, COVID-19, RSV, and Influenza
In the United Kingdom, the first.
-
Innovative Zika Virus Defense: Needle-Free Vaccine Patch
To protect individuals from the potentially.
-
Social Media Impact on Mental Health Treatment
According to research, social media might.
-
Unveiling the Impact of Whole Grain Consumption on Slowing Memory Decline in Black Populations
Consuming a diet rich in whole.
-
$1 Cancer Treatment: Engineered Bacteria Breakthrough
What if a single one-dollar dose.
-
Pfizer COVID Booster: Half-Dose, Reduced Side Effects
In a recent report in The.
Leave a Comment